Financial Survey: Surgery Partners (SGRY) and Its Rivals
Surgery Partners (NASDAQ: SGRY) is one of 15 publicly-traded companies in the “Hospitals, Clinics & Primary Care Services” industry, but how does it weigh in compared to its peers? We will compare Surgery Partners to similar companies based on the strength of its profitability, earnings, dividends, institutional ownership, analyst recommendations, risk and valuation.
Valuation & Earnings
This table compares Surgery Partners and its peers gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Surgery Partners||$1.15 billion||$9.45 million||-20.43|
|Surgery Partners Competitors||$1.06 billion||-$22.56 million||726.89|
This table compares Surgery Partners and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Surgery Partners Competitors||4.56%||4.29%||4.73%|
Institutional & Insider Ownership
94.2% of Surgery Partners shares are owned by institutional investors. Comparatively, 69.5% of shares of all “Hospitals, Clinics & Primary Care Services” companies are owned by institutional investors. 7.6% of Surgery Partners shares are owned by insiders. Comparatively, 10.4% of shares of all “Hospitals, Clinics & Primary Care Services” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Volatility & Risk
Surgery Partners has a beta of 1.92, meaning that its stock price is 92% more volatile than the S&P 500. Comparatively, Surgery Partners’ peers have a beta of 1.58, meaning that their average stock price is 58% more volatile than the S&P 500.
This is a summary of recent recommendations and price targets for Surgery Partners and its peers, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Surgery Partners Competitors||57||326||509||9||2.52|
Surgery Partners presently has a consensus target price of $18.00, indicating a potential upside of 91.49%. As a group, “Hospitals, Clinics & Primary Care Services” companies have a potential upside of 24.08%. Given Surgery Partners’ higher possible upside, analysts clearly believe Surgery Partners is more favorable than its peers.
Surgery Partners peers beat Surgery Partners on 8 of the 13 factors compared.
About Surgery Partners
Surgery Partners, Inc. is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services. The Company’s surgical facilities primarily provide non-emergency surgical procedures across a range of specialties, which include gastrointestinal (GI), general surgery, ophthalmology, orthopedics and pain management. The Company’s Ancillary Services segment consists of a diagnostic laboratory, a specialty pharmacy and multi-specialty physician practices. The Company’s physician practices include its owned and operated physician practices pursuant to long-term management service agreements. The Company’s Optical Services segment consists of an optical laboratory, an optical products group purchasing organization.
Receive News & Ratings for Surgery Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners Inc. and related companies with MarketBeat.com's FREE daily email newsletter.